Exosomal levels of miRNA-21 from cerebrospinal fluids associated with poor prognosis and tumor recurrence of glioma patients

Oncotarget

Volumn 6, Issue 29, 2015, Pages 26971-26981

  Shi, Rui ^a   Wang, Pei Yin ^b   Li, Xin Yi ^c   Chen, Jian Xin ^a   Li, Yan ^a   Zhang, Xin Zhong ^b   Zhang, Chen Guang ^a   Jiang, Tao ^d   Li, Wen Bin ^a   Ding, Wei ^a   Cheng, Shu Jun ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b XINXIANG MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

^d CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Cancer prognosis; Cerebrospinal fluid; Extracellular vesicles; Glioma; Hsa mir 21

Indexed keywords

ANTINEOPLASTIC AGENT; MICRORNA 21; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; APOPTOSIS REGULATORY PROTEIN; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; MICRORNA; MIRN21 MICRORNA, HUMAN; PDCD4 PROTEIN, HUMAN; PTEN PROTEIN, HUMAN; RECK PROTEIN, HUMAN; RNA BINDING PROTEIN; TUMOR MARKER;

ADULT; ARTICLE; CANCER GRADING; CANCER PROGNOSIS; CANCER SURGERY; CEREBROSPINAL FLUID; CONTROLLED STUDY; EXOSOME; FEMALE; GENE EXPRESSION; GENE TARGETING; GLIOMA; GLIOMA CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; ONCOGENE; OVERALL SURVIVAL; PDCD4 GENE; PTEN GENE; RECK GENE; TUMOR RECURRENCE; UPREGULATION; AGED; ASTROCYTOMA; BLOOD; BRAIN NEOPLASMS; DISEASE COURSE; EPENDYMOMA; GENE EXPRESSION REGULATION; GENETICS; GLIOBLASTOMA; KAPLAN MEIER METHOD; LENTIVIRINAE; METABOLISM; METASTASIS; MIDDLE AGED; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; RECURRENT DISEASE; TIME FACTOR; TRANSMISSION ELECTRON MICROSCOPY; TUMOR CELL LINE;

ADULT; AGED; APOPTOSIS REGULATORY PROTEINS; ASTROCYTOMA; BIOMARKERS, TUMOR; BRAIN NEOPLASMS; CELL LINE, TUMOR; DISEASE PROGRESSION; EPENDYMOMA; EXOSOMES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; GLIOMA; GPI-LINKED PROTEINS; HUMANS; KAPLAN-MEIER ESTIMATE; LENTIVIRUS; MALE; MICRORNAS; MICROSCOPY, ELECTRON, TRANSMISSION; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PTEN PHOSPHOHYDROLASE; RECURRENCE; RNA-BINDING PROTEINS; ROC CURVE; TIME FACTORS;

EID: 84944463325     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.4699     Document Type: Article

References (27)

1. Helseth R, Helseth E, Johannesen TB, Langberg CW, Lote K, Ronning P, Scheie D, Vik A, Meling TR. Overall survival, prognostic factors, and repeated surgery in a consecutive series of 516 patients with glioblastoma multiforme. Acta Neurol Scand. 2010; 122:159-67.
2. Server A, Kulle B, Maehlen J, Josefsen R, Schellhorn T, Kumar T, Langberg CW, Nakstad PH. Quantitative apparent diffusion coefficients in the characterization of brain tumors and associated peritumoral edema. Acta Radiol. 2009; 50:682-9.
3. Zakaria R, Das K, Radon M, Bhojak M, Rudland PR, Sluming V, Jenkinson MD. Diffusion-weighted MRI characteristics of the cerebral metastasis to brain boundary predicts patient outcomes. BMC Med Imaging. 2014; 14:26.
4. D'Asti E, Garnier D, Lee TH, Montermini L, Meehan B, Rak J. Oncogenic extracellular vesicles in brain tumor progression. Front Physiol. 2012; 3:294.
5. Vader P, Breakefield XO, Wood MJ. Extracellular vesicles: emerging targets for cancer therapy. Trends Mol Med. 2014; 20:385-93.
6. Katsuda T, Kosaka N, Ochiya T. The roles of extracellular vesicles in cancer biology: toward the development of novel cancer biomarkers. Proteomics. 2014; 14:412-25.
7. Turturici G, Tinnirello R, Sconzo G, Geraci F. Extracellular membrane vesicles as a mechanism of cell-to-cell communication: advantages and disadvantages. Am J Physiol Cell Physiol. 2014; 306:C621-33.
8. Shi Zhendong, Zhang Junxia, Qian Xiaomin, Han Lei, Zhang Kailiang, Chen Luyue, Liu Jilong, Ren Yu, Yang Ming, Zhang Anling, Pu Peiyu, Kang Chunsheng. AC1MMYR2, an Inhibitor of Dicer-Mediated Biogenesis of Oncomir miR-21, Reverses Epithelial-Mesenchymal Transition and Suppresses Tumor Growth and Progression. Cancer Res. 2013; 73:5519-5531.
9. Gao X, Jin W. The emerging role of tumor-suppressive microRNA-218 in targeting glioblastoma stemness. Cancer Lett. 2014; 353:25-31.
10. Zhao B, Bian EB, Li J. New advances of microRNAs in glioma stem cells, with special emphasis on aberrant methylation of microRNAs. J Cell Physiol. 2014; 229:1141-7.
11. Chan JA, Krichevsky AM, Kosik KS. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res. 2005; 65:6029-33.
12. Gabriely G, Wurdinger T, Kesari S, Esau CC, Burchard J, Linsley PS, Krichevsky AM. MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators. Mol Cell Biol. 2008; 28:5369-80.
13. Dickerson EB, Blackburn WH, Smith MH, Kapa LB, Lyon LA, McDonald JF. Chemosensitization of cancer cells by siRNA using targeted nanogel delivery. BMC Cancer. 2010; 10:10.
14. Park YM, Hwang SJ, Masuda K, Choi KM, Jeong MR, Nam DH, Gorospe M, Kim HH. Heterogeneous nuclear ribonucleoprotein C1/C2 controls the metastatic potential of glioblastoma by regulating PDCD4. Mol Cell Biol. 2012; 32:4237-44.
15. Zhang J, Li S, Li L, Li M, Guo C, Yao J, Mi S. Exosome and exosomal microRNA: trafficking, sorting, and function. Genomics Proteomics Bioinformatics. 2015; 13:17-24.
16. Rani S. MicroRNA profiling of exosomes isolated from biofluids and conditioned media. Methods Mol Biol. 2014; 1182:131-44.
17. Zhao L, Liu W, Xiao J, Cao B. The role of exosomes and "exosomal shuttle microRNA" in tumorigenesis and drug resistance. Cancer Lett. 2015; 356:339-46.
18. Maachani UB, Tandle A, Shankavaram U, Kramp T, Camphausen K. Modulation of miR-21 signaling by MPS1 in human glioblastoma. Oncotarget. 2015.
19. Ferracin M, Lupini L, Salamon I, Saccenti E, Zanzi MV, Rocchi A, Da Ros L, Zagatti B, Musa G, Bassi C, Mangolini A, Cavallesco G, Frassoldati A, Volpato S, Carcoforo P, Hollingsworth AB, Negrini M. Absolute quantification of cell-free microRNAs in cancer patients. Oncotarget. 2015.
20. Theodoropoulou S, Sutherland MS, Haddow K, Blaikie A. Success rates of endoscopic-assisted probing for congenital nasolacrimal duct obstruction in children. J Laryngol Otol. 2013; 127:794-8.
21. Li M, Rai AJ, Joel DeCastro G, Zeringer E, Barta T, Magdaleno S, Setterquist R, Vlassov AV. An optimized procedure for exosome isolation and analysis using serum samples: Application to cancer biomarker discovery. Methods. 2015.
22. McCubrey JA, Steelman LS, Chappell WH, Abrams SL, Franklin RA, Montalto G, Cervello M, Libra M, Candido S, Malaponte G, Mazzarino MC, Fagone P, Nicoletti F, Basecke J, Mijatovic S, Maksimovic-Ivanic D, Milella M, Tafuri A, Chiarini F, Evangelisti C, Cocco L, Martelli AM. Ras/Raf/ MEK/ERK and PI3K/PTEN/Akt/mTOR cascade inhibitors: how mutations can result in therapy resistance and how to overcome resistance. Oncotarget. 2012; 3:1068-111.
23. Keerthikumar S, Gangoda L, Liem M, Fonseka P, Atukorala I, Ozcitti C, Mechler A, Adda CG, Ang CS, Mathivanan S. Proteogenomic analysis reveals exosomes are more oncogenic than ectosomes. Oncotarget. 2015.
24. Barbano R, Palumbo O, Pasculli B, Galasso M, Volinia S, D'Angelo V, Icolaro N, Coco M, Dimitri L, Graziano P, Copetti M, Valori VM, Maiello E, Carella M, Fazio VM, Parrella P. A miRNA signature for defining aggressive phenotype and prognosis in gliomas. PLoS One. 2014; 9:e108950.
25. Teplyuk NM, Mollenhauer B, Gabriely G, Giese A, Kim E, Smolsky M, Kim RY, Saria MG, Pastorino S, Kesari S, Krichevsky AM. MicroRNAs in cerebrospinal fluid identify glioblastoma and metastatic brain cancers and reflect disease activity. Neuro Oncol. 2012; 14:689-700.
26. Zhu J, Sun L, Lin S, Zhao R, Zhou L, Fang D, Chen L, Liu J, Shi W, Zhang L, Yuan S. BlyS is up-regulated by hypoxia and promotes migration of human breast cancer cells. J Exp Clin Cancer Res. 2012; 31:31.
27. Akers JC, Ramakrishnan V, Kim R, Skog J, Nakano I, Pingle S, Kalinina J, Hua W, Kesari S, Mao Y, Breakefield XO, Hochberg FH, Van Meir EG, Carter BS, Chen CC. MiR-21 in the extracellular vesicles (EVs) of cerebrospinal fluid (CSF): a platform for glioblastoma biomarker development. PLoS One. 2013; 8:e78115.